Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2025-12-24 @ 7:35 PM
NCT ID:
NCT00006903
Brief Title:
Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer
Official Title:
Phase II Study of Faslodex ? in Recurrent/Metastatic Endometrial Carcinoma
Study:
NCT00006903
Protocol Section:
NCT00006903